NAFDAC: Deleject Disposable Needle Batch No. 240605 Public Alert Raises Quality Concerns

• NAFDAC issued Public Alert No. 042/2026 regarding Deleject Disposable Needle Batch No. 240605 on August 10, 2026.
• The alert concerns the presence of whitish particulate matter, and laboratory investigation confirmed the product was unsatisfactory.
• There are currently quality, safety, and regulatory issues with the product, and NAFDAC advises against its use.
• The alert has significant implications for lawyers and their clients involved in medical device regulation in Nigeria.

The National Agency for Food and Drug Administration and Control (NAFDAC) is alerting healthcare professionals, distributors, retailers, and the public of the presence of whitish particulate matter discovered on Deleject Disposable Needles, Batch No. 240605.

In a move that has significant implications for medical device regulation in Nigeria, the National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public alert regarding the Deleject Disposable Needle Batch No. 240605. The alert, Public Alert No. 042/2026, was issued on August 10, 2026, raising concerns about the presence of whitish particulate matter in the needles. According to NAFDAC, a laboratory investigation confirmed that the product was unsatisfactory.

The NAFDAC's alert highlights the importance of a robust regulatory review process for medical devices in Nigeria. The agency's review and investigation into the Deleject Disposable Needle Batch No. 240605 identified quality, safety, and regulatory issues with the product, confirming it was unsatisfactory. This outcome underscores the effectiveness of NAFDAC's regulatory framework in ensuring that medical devices meet stringent standards before they are approved for use in the country.

The alert by NAFDAC has significant implications for lawyers and their clients involved in the importation, distribution, or sale of medical devices in Nigeria. The public alert raises concerns about potential product liability claims arising from the identified issues. With NAFDAC's confirmation of quality, safety, and regulatory issues with the Deleject Disposable Needle Batch No. 240605, it is clear that the product is deemed unsatisfactory. This development underscores the importance of staying informed about regulatory updates and alerts to avoid compliance exposure and ensure public safety.

Lawyers should watch for potential product liability claims arising from the initial public alert, and ensure clients are aware of NAFDAC's clarification to avoid unnecessary compliance exposure.

Source: Original reporting via NAFDAC website